(Q44356537)

https://doi.org/10.1016/j.jconrel.2016.05.025

2 December 2017

1 reference

29 December 2023

http://retractionwatch.com/2016/07/22/four-more-retractions-for-biomaterials-researcher-brings-total-to-7/

http://retractionwatch.com/2016/02/12/journal-breaks-3-bone-papers-for-duplication-by-same-author/

title

Tumor targeting of gene expression through metal-coordinated conjugation with dextran (English)

1 reference

2 December 2017

4

Yasuhiko Tabata

1 reference

2 December 2017

Hossein Hosseinkhani

1

1 reference

2 December 2017

Teruyoshi Aoyama

series ordinal

2

1 reference

2 December 2017

Osamu Ogawa

series ordinal

3

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Journal of Controlled Release

2 December 2017

published in

1 reference

2 December 2017

volume

88

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

297-312

1 reference

The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Systemic administration of TerplexDNA system: pharmacokinetics and gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Tumor targeting with surface-shielded ligand--polycation DNA complexes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Development of non-viral vectors for systemic gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Improved DNA: liposome complexes for increased systemic delivery and gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

New amphipatic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Gene Transfer In Vivo with DNA–Liposome Complexes: Safety and Acute Toxicity in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Systemic gene expression after intravenous DNA delivery into adult mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Polyethylenimine-based intravenous delivery of transgenes to mouse lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Biodistribution and gene expression of lipid/plasmid complexes after systemic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Antitumor activity of bax and p53 naked gene transfer in lung cancer: in vitro and in vivo analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

In vivo delivery to tumors of DNA complexed with linear polyethylenimine.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Gene therapy strategies for tumor antiangiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Antibody conjugates for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Monoclonal antibodies. Future potential in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Strategies in antibody therapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Cancer-targeted polymeric drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Tumor accumulation of poly(vinyl alcohol) of different sizes after intravenous injection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Water soluble polymers in tumor targeted delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Drug-polymer conjugates: potential for improved chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Pharmacokinetic characteristics and therapeutic effects of mitomycin C-dextran conjugates after intratumoural injection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Disposition characteristics of macromolecules in tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Liposome-based drug delivery in breast cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Pegylation: engineering improved pharmaceuticals for enhanced therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Treating cancer with PEG Intron: pharmacokinetic profile and dosing guidelines for an improved interferon-alpha-2b formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Perspectives of pegylated interferon use in dermatological oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Phase II trial of pegylated-liposomal doxorubicin (Doxil) in renal cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Demonstration of the receptor-mediated hepatic uptake of dextran in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Disposition and tumor localization of mitomycin C-dextran conjugates in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Preparation and properties of the immunoconjugate composed of anti-human colon cancer monoclonal antibody and mitomycin C-dextran conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Tumor localization and in vivo antitumor activity of the immunoconjugate composed of anti-human colon cancer monoclonal antibody and mitomycin C-dextran conjugate.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Pharmacokinetics of methotrexate-albumin conjugates in tumor-bearing rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Targeting of tumor necrosis factor to tumor by use of dextran and metal coordination

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Liver targeting of interferon through pullulan conjugation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Liver targeting of plasmid DNA by pullulan conjugation based on metal coordination

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Evidence for receptor-mediated hepatic uptake of pullulan in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

Zinc ion-DNA polymer interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

A method for preparing chelate-cytokine conjugates with retention of protein structure, biological activity, and pharmacokinetic properties

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900425-X

7 January 2021

10.1016/S0168-3659(02)00425-X

Identifiers

DOI

1 reference

2 December 2017

1 reference